Leukemia, Myeloid, Chronic [clinicaltrials_resource:92d186e0b52759b64d0a939e10979333]
Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) [clinicaltrials:NCT00034684]clinicaltrials:NCT00040105clinicaltrials:NCT00050531AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™ [clinicaltrials:NCT00058747]clinicaltrials:NCT00067002Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia [clinicaltrials:NCT00167167]clinicaltrials:NCT00167180clinicaltrials:NCT00176930Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies [clinicaltrials:NCT00186342]Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies [clinicaltrials:NCT00246662]Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy [clinicaltrials:NCT00264160]A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate [clinicaltrials:NCT00298987]T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation [clinicaltrials:NCT00306332]clinicaltrials:NCT00320190clinicaltrials:NCT00393380clinicaltrials:NCT00406393Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis) [clinicaltrials:NCT00449761]Safety Assessment of a Multipeptide-gene Vaccine in CML [clinicaltrials:NCT00455221]An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase [clinicaltrials:NCT00538109]Prospective Database for Chronic Myelogenous Leukemia [clinicaltrials:NCT00538447]Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers [clinicaltrials:NCT00539656]Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia [clinicaltrials:NCT00732186]Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects [clinicaltrials:NCT00759837]Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive [clinicaltrials:NCT00763763]Unrelated Double Umbilical Cord Blood Units Transplantation [clinicaltrials:NCT01015742]clinicaltrials:NCT01050946The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) [clinicaltrials:NCT02269267]
condition [clinicaltrials_vocabulary:condition]
Leukemia, Myeloid, Chronic [clinicaltrials_resource:92d186e0b52759b64d0a939e10979333]
Bio2RDF identifier
92d186e0b52759b64d0a939e10979333
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:92d186e0b52759b64d0a939e10979333
identifier
clinicaltrials_resource:92d186e0b52759b64d0a939e10979333
title
Leukemia, Myeloid, Chronic
@en
label
Leukemia, Myeloid, Chronic [clinicaltrials_resource:92d186e0b52759b64d0a939e10979333]
@en